Research. Advocacy. Support.
We advance ovarian cancer research while supporting women and their families.
Register for OCRFA's Ovarian Cancer National Conference
Join us for an informative and transformative weekend of inspiration and hope, July 13-15 in Washington DC. Meet other survivors, patients and caregivers, hear from experts, and make lasting connections with others who have been touched by ovarian cancer.
Know Your Risks
About 20 to 25 percent of women diagnosed with ovarian cancer have a hereditary tendency to develop the disease.
Many factors can increase or decrease a woman's risk of developing ovarian cancer.
- Family history of breast, ovarian or colon cancer
- Genetic mutations like BRCA
- Increased age
- Use of oral contraceptives
Know the Symptoms
- Difficulty Eating
- Pelvic / Abdominal Pain
- Urinary Frequency
If these symptoms occur for more than 2 weeks and these symptoms are new or unusual for you, see a gynecologist and ask about ovarian cancer. Research shows that seeing a gynecologic oncologist for surgery and treatment significantly improves outcomes.
Spring Advocacy Day
OCRFA and our amazing advocates brought #TealAction to Capitol Hill on March 6, highlighting the need for increased ovarian cancer research funding and support at the federal level. Together, we are the voice of the ovarian cancer community. Join us for our next Advocacy Day on July 16th!
(May 18, 2018) Just last month, three of OCRFA’s research advocates attended the 5 day AACR meeting in Chicago, Illinois to learn about new therapies and innovative technology, stay up to date on current projects, and attend lectures from ovarian cancer researchers such as Dr. Anil Sood of MD Anderson and Dr. Dineo Khabele of… More
Hormone Replacement Therapy After Oophorectomy Is Not Shown to Increase Risk of Breast Cancer in BRCA1 Mutation Carriers
(May 4, 2018) JAMA Oncology recently published a study that looked at the risk of breast cancer in BRCA1 carriers who underwent a prophylactic bilateral salpingo-oophorectomy, a surgery that removes both ovaries before any sign of disease, followed by hormone replacement therapy (HRT). Eight hundred and seventy two women were followed for around 7.5 years… More
(April 27, 2018) An OCRFA supported study, recently published in Oncogene, delved into the mechanics of how ovarian cancer spreads throughout the body. Researchers at Johns Hopkins, including OCRFA grantee and lead author Ie-Ming Shih, MD, PhD, investigated spleen tyrosine kinase (SYK), which is heavily involved in ovarian cancer tumor progression, in an effort to… More
OCRFA’s indoor cycling event comes to Pittsburgh on June 3, 2018. Ride for a cure for ovarian ...June 3 @ 1:30 pm - 2:45 pm EDT
OCRFA’s 2018 Conference will be held July 13-15, in Washington, DC. The conference will be fol...July 13 - July 15
On July 16th, join survivors, caregivers and Ovarian Cancer Research Fund Alliance in Washington, DC...July 16 @ 8:00 am - 5:00 pm EDT